BioMedNewsBreaks – XSurgical to Host July 11 Webinar

XSurgical Inc., an artificial intelligence surgical robotics company, has announced that it will host a Q&A webinar at 11 a.m. Pacific Time on July 11, 2023. Led by co-founder and CEO Dr. Gianluca De Novi and Chairman of the Board Michele Marzola, the focus of the online event will be to discuss XSurgical as a business, as well as the company’s equity crowdfunding raise on Netcapital. With an innovative, unique approach, the company’s mission is to democratize surgical robotics by creating a versatile platform accessible to a much broader population worldwide. Interested parties should visit https://ibn.fm/x4bXw to save a spot and access the webinar.

To view the full press release, visit https://ibn.fm/QZCkM

About XSurgical

XSurgical’s system uses AI and machine learning to perform a range of procedures with precision and accuracy, while remaining affordable and easily deployable. By aiming to offer these solutions, XSurgical is working toward making surgical robotics more cost-effective, efficient and accessible, thereby improving patient outcomes and increasing the utilization of surgical robots in a variety of environments.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — Rare Biotech Story: Nutriband Inc. (NASDAQ: NTRB) Featured on Smart Money Podcast

Nutriband (NASDAQ: NTRB) was recently featured on the Smart Money Circle Show, where Serguei Melnik, NTRB’s founder…

2 days ago

BioMedNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Featured in NetworkNewsWire Spotlight on Genetic Medicines 

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotech innovator, announced its inclusion in an editorial…

2 days ago

BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Raises $4.6 Million Through Warrant Exercise Agreement

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotech firm developing targeted therapies for genetic medicine…

3 days ago

BioMedNewsBreaks — Adageis’ Platform Tackles Healthcare Complexities with AI

Adageis was featured in a recent article that discussed its powerful and patented AI-centric software solution.…

4 days ago

BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Lead Program in Virtual CEO Segment 

  CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on treating primary and metastatic cancers…

4 days ago

BioMedNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Targets Multiple 2025–2026 Catalysts Across Rare Disease Pipeline

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical…

4 days ago